Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
Cleveland Clinic Journal of Medicine. 2006 May;73(5):477-484
May 1, 2006|Type 2 Diabetes ICYMI
Author and Disclosure Information
ABSTRACTInsulin is not the only hormone that regulates plasma glucose levels. Glucagon-like peptide 1 (GLP-1), produced in the small intestine, and amylin, produced by beta cells in the pancreas, also have glucose-lowering effects. Synthetic analogues of these hormones are now available for clinical use.
